159 related articles for article (PubMed ID: 22006521)
1. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes.
Roland CL; Bian A; Mansour JC; Yopp AC; Balch GC; Sharma R; Xie XJ; Schwarz RE
J Surg Oncol; 2012 May; 105(6):595-600. PubMed ID: 22006521
[TBL] [Abstract][Full Text] [Related]
2. Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis.
Keutgen XM; Nilubol N; Kebebew E
Surgery; 2016 May; 159(5):1382-9. PubMed ID: 26704781
[TBL] [Abstract][Full Text] [Related]
3. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
Fernández-Cruz L; Blanco L; Cosa R; Rendón H
World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
[TBL] [Abstract][Full Text] [Related]
4. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic neuroendocrine tumours.
Ruiz-Tovar J; Priego P; Martínez-Molina E; Morales V; Sanjuanbenito A; Lobo E
Clin Transl Oncol; 2008 Aug; 10(8):493-7. PubMed ID: 18667380
[TBL] [Abstract][Full Text] [Related]
6. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
7. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
8. Surgical resection of high-grade nonfunctional pancreatic neuroendocrine carcinoma is associated with improved survival.
Jiang J; Park J; Kim S; Daan A; Donahue T; Girgis MD
J Surg Oncol; 2021 Dec; 124(8):1373-1380. PubMed ID: 34406651
[TBL] [Abstract][Full Text] [Related]
9. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
Chivukula SV; Tierney JF; Hertl M; Poirier J; Keutgen XM
Surgery; 2020 Jan; 167(1):180-186. PubMed ID: 31537303
[TBL] [Abstract][Full Text] [Related]
10. Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas.
Bloomston M; Muscarella P; Shah MH; Frankel WL; Al-Saif O; Martin EW; Ellison EC
J Gastrointest Surg; 2006 Dec; 10(10):1361-70. PubMed ID: 17175455
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic islet cell tumors in adolescents and young adults.
Waters AM; Maizlin II; Russell RT; Dellinger M; Gow KW; Goldin A; Goldfarb M; Nuchtern JG; Langer M; Vasudevan SA; Doski JJ; Raval M; Beierle EA
J Pediatr Surg; 2019 Oct; 54(10):2103-2106. PubMed ID: 30954230
[TBL] [Abstract][Full Text] [Related]
12. [Hormone inactive neuroendocrine tumors of the pancreas].
Schwab M; Knoll MR; Jentschura D; Hagmüller E
Chirurg; 1997 Jul; 68(7):705-9. PubMed ID: 9340236
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in resected pancreatic neuroendocrine tumours: Experience in 95 patients.
Sánchez-Bueno F; Rodríguez González JM; Torres Salmerón G; Bernabé Peñalver A; Balsalobre Salmeron M; de la Peña Moral J; Fuster Quiñonero M; Parrilla Paricio P
Cir Esp; 2016 Oct; 94(8):473-80. PubMed ID: 27450270
[TBL] [Abstract][Full Text] [Related]
14. Management of nonfunctioning islet cell tumors.
Liang H; Wang P; Wang XN; Wang JC; Hao XS
World J Gastroenterol; 2004 Jun; 10(12):1806-9. PubMed ID: 15188511
[TBL] [Abstract][Full Text] [Related]
15. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients.
Phan GQ; Yeo CJ; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL
J Gastrointest Surg; 1998; 2(5):472-82. PubMed ID: 9843608
[TBL] [Abstract][Full Text] [Related]
16. Extended surgery for advanced pancreatic endocrine tumours.
Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
[TBL] [Abstract][Full Text] [Related]
17. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
Ye H; Xu HL; Shen Q; Zheng Q; Chen P
J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
[TBL] [Abstract][Full Text] [Related]
19. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
20. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors.
Schmitt AM; Anlauf M; Rousson V; Schmid S; Kofler A; Riniker F; Bauersfeld J; Barghorn A; Probst-Hensch NM; Moch H; Heitz PU; Kloeppel G; Komminoth P; Perren A
Am J Surg Pathol; 2007 Nov; 31(11):1677-82. PubMed ID: 18059224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]